Research Article

Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry

Table 2

Clinical characteristics.

n472
Age (years)61.5  ±  11.2
Male gender (n, %)391 (83)
Weight (Kg)78.8  ±  14.6
History of smoking (n, %)287 (61)
Diabetes mellitus (n, %)79 (17)
Hypertension (n, %)247 (53)
Dyslipidemia (n, %)208 (45)
Previous myocardial infarction (n, %)48 (10)
Previous TIA/stroke (n, %)18 (4)
Previous PCI (n, %)57 (12)
Previous CABG (n, %)12 (3)
STEMI location (n, %)
 Anterior217 (46)
 Nonanterior253 (54)
Killip class 3-412 (2.5)
Heart rate (bpm)77 ± 18
Systolic blood pressure (mmHg)134 ± 27
Hemoglobin (g/dl)14.5 ± 2.5
Hematocrit (%)42.5 ± 5.8
GFR (ml/min)82.1 ± 23.5